Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Robson

Showing results (291-300 of 299) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 299 results.
Nature Genetics|October 27, 2020
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L Bolton, Ryan N Ptashkin, Teng Gao, et al.
Cell|February 5, 2022
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patientsBastien Nguyen, Christopher Fong, Anisha Luthra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017Veda N Giri, Karen E Knudsen, William K Kelly, et al.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Cancer Research|November 15, 2019
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.
Pageof 30

Showing results (291-300 of 299) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 299 results.
Nature Genetics|October 27, 2020
Cancer therapy shapes the fitness landscape of clonal hematopoiesisKelly L Bolton, Ryan N Ptashkin, Teng Gao, et al.
Cell|February 5, 2022
Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patientsBastien Nguyen, Christopher Fong, Anisha Luthra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 14, 2017
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017Veda N Giri, Karen E Knudsen, William K Kelly, et al.
Cancer Cell|March 27, 2026
Cancer type-specific variation in patterns of driver alterations across 50,000 tumorsChaitanya Bandlamudi, Daniel Muldoon, Ino de Bruijn, et al.
Nature Medicine|May 9, 2017
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patientsAhmet Zehir, Ryma Benayed, Ronak H Shah, et al.
Nature Communications|May 13, 2020
Protein-altering germline mutations implicate novel genes related to lung cancer developmentXuemei Ji, Semanti Mukherjee, Maria Teresa Landi, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 22, 2012
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersFergus J Couch, Mia M Gaudet, Antonis C Antoniou, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 23, 2014
Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriersPaolo Peterlongo, Jenny Chang-Claude, Kirsten B Moysich, et al.
Cancer Research|November 15, 2019
Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and AggressivenessVivek L Patel, Evan L Busch, Tara M Friebel, et al.
Pageof 30